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Prevailing theories view aging as an outcome of both 
programmed and stochastic events that occur over the 
lifetime of the individual. In this context, aging can be 
defined as a progressive decline in homeostasis and a 
period characterized by the inability of the organism to 
respond adaptively to stress. Apoptosis thus stands out 
as a potential key cellular process that may be affected 
during aging because apoptosis is both an important 
homeostatic mechanism and a protective cellular 
response to stress. In this paper we introduce the topic 
of apoptosis, its regulation, and its roles in epidermal 
I s apoptosis a contributing mechanism of skin aging? To date, with the exception of the process of neoplastic transformation, there is very litde direct evidence on which to base evaluation of this question. It is informative, however, to consider the features and regulation of the apoptotic process, and the specific 
roles of apoptosis in the skin. Some insights may also be gained by 
drawing parallels between mechanisms that control apoptosis and 
mechanisms that are dysregulated in aged skin. 
APOPTOSIS: DEFINITION, INCIDENCE, AND FUNCTIONS 
Apoptosis is an evolutionarily conserved, gene-directed, active cell 
death that follows an orderly pattern of morphologic and biochemical 
changes. Cornmon histologic observations have established that a strict 
sequence of events is shared by all apoptotic cells. These include loss 
of cell contact accompanied by cell rounding and a smoothing of the 
cell surface, loss of cytoskeletal integrity, cell shrinkage with resultant 
compaction of the cytoplasm and organelles, nuclear and chromatin 
condensation, chromatin fragmentation, formation of apoptotic bodies , 
and engulfinent. Throughout the various tissues of the organism 
apoptosis normally functions in developmental remodeling, regulation 
of cell numbers, and defense against damaged, virus-infected, auto­
reactive, and transformed cells (Kerr et ai, 1992; McConkey and 
Orrenius, 1994; Polakowska et ai, 1994). 
REGULATION OF APOPTOSIS: PRIVATE AND PUBLIC 
PATHWAYS 
The fact that apoptosis is gene-directed has spurred an enormous 
number of studies because of the obvious biologic and medical 
significance of a form of cell death that can be modulated. Much of 
what we understand today about control of apoptosis comes from 
studies of invertebrate systems with powerful genetics such as the 
nematode Caenorhabdhitis elegans and the fruitfiy, Drosophila melanogaster. 
Fortuitously, broad evolutionary conservation of the mechanism of 
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homeostasis as a feature of normal keratinocyte differenti­
ation and as a cellular endpoint of stress. To probe the 
question of whether apoptosis contributes to the process 
of skin aging, we present evidence for apoptotic dysregul­
ation during aging in nonskin systems and discuss some 
findings suggesting that decreased efficiency of apoptosis 
may contribute to the alterations characteristic of intrinsic 
(chronologie) aging and extrinsic (photo aging) skin 
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apoptosis, and its regulation, allows us to generalize much of what is 
known in these organisms to mammalian cells, and also provides us 
with the tools to search for genetic homologies. The agents and events 
(growth factors, hormones, cytokines, UV and gamma irradiation, 
disruption in oxidative pathways , and cell matrix interactions) that can 
activate the apoptotic pathway (reviewed in McConkey and Orrenhius, 
1994; Kroemer et ai, 1995) are many and varied, yet, the pattern of 
apoptosis itself is highly conserved. This has led researchers in the field 
to hypothesize that there must be a limited number of shared effector 
mechanisms that trigger a cornmon apoptotic pathway (Vaux and 
Strasser, 1996; Kroemer et ai, 1995, 1997; Wyllie, 1995), an idea that 
has held true. Moreover, the identification and characterization of 
individual events and regulatory points along the apoptotic pathway 
in these experimental systems (Wyllie, 1995; Kroemer et ai, 1997), 
have allowed the development of conceptual models that divide the 
pathway into three mechanistically distinct phases; induction, effector, 
and degradation [see Haake and Polakowska (1997) for a review in 
the context of epidermal differentiation] . 
The induction phase also has been referred to as the initiation or 
signaling phase (Kroemer et aI, 1995). Although the ultimate trigger 
of apoptosis has not been established, many proximate inducing 
conditions (see above) have been identified. In the induction phase, 
these heterogeneous stimuli activate receptor- and nonreceptor-medi­
ated signal transduction pathways and second messengers such as cAMP, 
inositol triphosphate, diacylglycerol, and cerarnides (McConkey and 
Orrenius, 1994; Hunan and Obeig, 1995). The pathways are not 
reserved for apoptotic signaling but also are used for other cellular 
functions, such as growth control. The outcome of signaling depends 
on the particular inducing stimulus (which may affect one or more 
signal transduction pathways) , the developmental or physiologic state 
of the cell, and the cell's lineage. Thus, a given stimulus may elicit a 
cell type-specific response. For these reasons the signaling pathways of 
the induction phase have been referred to as the "private" pathways 
(Kroemer et ai, 1997). A common outcome of the different signal 
transduction pathways that impacts on apoptosis is interference with 
the cell cycle. A major control of apoptotic susceptibility is determined 
by the cell cycle and it's checkpoints (King and Cidlowski, 1995) that 
prevent aberrant DNA synthesis and mitosis. It is of relevance for this 
discussion that many of the major cell cycle regulatory genes that have 
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been identified as important in the control of apoptosis, also have 
been implicated in the aging process . Some examples are the tumor 
suppressors p53 and Rb, and the c-fos proto-oncogene. Although 
apoptosis can be induced from any phase of the cell cycle (Bertrand 
et aI, 1994), entry into the cell death pathway usually occurs with re­
entry of noncycling cells into the cycle or entry onto a defective cell 
cycle (Colombel et ai, 1992). There is some evidence that entry into 
apoptosis may require at least partial cycling (pandey and Wang, 1995), 
providing a possible mechanistic explanation of the failure of senescent 
cells to undergo apoptosis (Wang, 1995). 
The evolutionarily conserved effector pathway, common to all cell 
types, is regulated by distinct classes of "cell death genes ." For example, 
genes of the bcl-2 family (Cory, 1995) can suppress cell death at the 
transition from induction to effector phases. Many viral proteins such 
as human papilloma virus (HPV) E6 and E7, SV40 T, and adenovirus 
E1 A, also inhibit cellular proteins controlling the induction phase of 
apoptosis and are effective in cell immortalization. Some genes are 
essential for cell death and appear to function in the common effector 
phase. In C. elegans, these genes are CED-3 and CED-4. CED-3 has 
homology with the mammalian interleukin 1-� converting enzyme 
(ICE), a cysteine protease belonging to the caspase family (Nicholson 
and Thornberry, 1997) . Recently, a mammalian homolog of CED-4, 
known as Apoptosis activating factor-1 (Apaf-1), has been discovered 
(Zou et ai, 1997). Apaf-1 is a novel 130 kDa protein isolated from 
HeLa cell cytosol that partipates in activation of caspase-3 and may 
bind to Bcl-2 (Zou et aI, 1997). The precise configuration of interaction 
among Bcl-2, Apaf-1 , and caspases has yet to be determined; however, 
much information regarding this critical regulatory step of apoptosis is 
already available. Interestingly, the mitochondrion appears to be a key 
player in apoptosis control as it is in the aging process (Ozawa, 1997) . 
Important early effector mechanisms involving mitochondria, and 
which possibly trigger apoptosis, have recently been identified. These 
mechanisms involve mitochondrial permeability transition (Kroemer 
et ai, 1997) and release of cytochrome C from the inner mitochondrial 
membrane into the cytoplasm , which can then activate the caspases 
(Kluck et ai, 1997; Yang et ai, 1997). Mitochondrial events appear to 
be upstream of Bcl-2 in the pathway as both permeability transition 
and cytochrome C release can be prevented by Bcl-2 overexpression 
(Kluck et ai, 1997). Bcl-2 also may inhibit caspase activation by binding 
directly to the Apaf-1 adaptor protein (Zou et ai, 1997; see also Vaux, 
1997). Once activated, the caspases target cellular structural proteins, 
such as actin and nuclear lamins, and proteins involved in DNA 
repair, including poly(ADP-ribosyl)polymerase. Caspases activate other 
effector proteins involved in degradation, possibly including additional 
proteases, endonucleases, and transglutarninases that are present in 
inactive forms within most cell types. The apoptotic pathway becomes 
irreversible with the activation of proteases and endonucleases that 
catalyze structural changes in the nucleus, cytoplasm, and cell mem­
branes, resulting in the characteristic morphologic cascade typifying 
apoptosis. This execution of cell death during the effector and 
degradative phases results in the stereotypical biochemical and morpho­
logic changes that have come to typify the apoptotic cell seen under 
the microscope or detected by other means. 
The above regulatory steps, and the genes controlling them, will be 
important to consider as prime candidates when looking for evidence 
of age-related apoptotic dysregulation. Moreover, these will be key 
points for targeting future modulation of apoptosis for therapeutic 
purposes. 
APOPTOSIS IS A CRITICAL COMPONENT OF EPIDERMAL 
HOMEOSTASIS 
The epidermis is a continually renewing tissue in which homeostasis 
is maintained by factors that influence the interrelated processes of 
keratinocyte proliferation, differentiation, senescence, and cell death. 
Changes in genes controlling these processes, in particular the balance 
between cell birth and cell death and the response to environmental 
stress, may contribute to changes in the skin associated with intrinsic 
and extrinsic skin aging. 
An important feature of homeostasis in the epidermis is regulation 
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of total cell numbers. Elegant studies of cell kinetics in the amphibian 
epidermis (Budtz and Spies, 1987) have established that apoptosis is a 
controlling factor of the cell birth to cell death ratio . New cells are 
produced in the proliferative compartment, primarily the basal cell 
layer, and are balanced by cell death (terminal differentiation/apoptosis). 
In the toad more cells are produced than are needed to replace 
terminally differentiated keratinocytes that are lost by desquamation. 
As a balancing mechanism, a significant number of cells become 
apoptotic without completing differentiation. In human skin it is not 
so clear that excessive keratinocytes are normally produced in the 
basal cell layer. The majority of cells therefore complete terminal 
differentiation, which itself may be an elaborated apoptotic pathway 
(Fesus et aI, 1991; Haake and Polakowska, 1993; Polakowska and 
Haake, 1994) . If the apoptotic pathway is the foundation ofkeratinocyte 
terminal differentiation , it follows that apoptosis must be completed 
for normal epidermal function. Moreover, as suggested by Raff (1992) 
for all cell types, there is some evidence in the epidermis that apoptosis 
is the default pathway taken when homeostatic regulation goes awry. 
One would predict then that premature apoptotic cells may be found 
in the spinous and basal cell layers, in cases of homeostatic dysregulation 
or after environmental insult, or that failure to complete apoptosis 
would result in retention of nuclei beyond the granular layer. Indeed, 
premature, excessive, or deficient apoptosis all have been linked to 
homeostatic dysregulation characteristic of skin disorders. For example, 
there is increasing evidence that apoptotic dysregulation contributes to 
the hyperplasia and aberrant differentiation typical of the psoriatic 
plaque (Bianchi et aI, 1994), and it has been suggested that dyskeratosis 
in the epidermis of patients with the genodermatosis Darier's Disease 
results from excessive or premature apoptosis (paus et aI, 1993) . It 
would not be surprising, then, to fmd apoptotic dysregulation as an 
important component of the process of skin aging . 
APOPTOSIS IS A CELLULAR ENDPOINT OF THE STRESS 
RESPONSE 
The skin, as the body's primary interface with the environment, must 
have functional cellular and molecular defense mechanisms against 
environmental insult in order to maintain homeostasis. Hence , age­
related changes in the skin cell's ability to res pond adaptively to stress, 
such as by induction of apoptosis, may contribute to aging . UV light 
is the major extrinsic factor impinging on the skin and it is well 
established that UV exposure leads to age-related changes in skin 
architecture (photoaging) and epidermal carcinogenesis . UV damages 
lipids, proteins, and DNA (Tyrell, 1996) and also generates reactive 
oxygen species and leads to stimulation of signal transduction pathways 
associated with the stress response (Kyriakis and Avruch, 1996). A 
frequent outcome ofUV exposure of the skin is induction of apoptosis 
resulting in the formation of the well-known epidermal "sunburn cell" 
(Young, 1987; reviewed in Haake and Polakowska' 1997). Apoptosis 
serves to remove the damaged cell from the tissue, thus making an 
important contribution to the multifaceted recovery processes of the 
epidermis after UV damage (Bernerd and Asselineau, 1997). Basal cells 
appear to be most susceptible, as evidenced by the fact that they are 
the first to undergo apoptosis following UV exposure . Sunburn cell 
formation in the proliferative compartment is consistent with the 
finding that keratinocytes in the S-phase of the cell cycle are sensitive 
to UV-induced apoptosis (Darmo and Horio, 1982). Later-appearing 
suprabasal apoptotic keratinocytes may result from delayed apoptosis 
and/ or outward transit of dying basal cells (Haake and Polakowska, 
1995). 
The formation of the sunburn cell is coordinated by genes that 
regulate the apoptotic pathway, and which therefore are important to 
consider as candidates for age-related dysfunction. UV-induced DNA 
damage triggers p53 and p21 induction (Lui and Pelling , 1995). UV 
also induces p53-independent keratinocyte apoptosis, possibly via 
membrane triggered signal transduction pathways (Gillardon et aI, 
1994). Overexpression ofBcl-2 or pretreatment with tumor promoting 
phorbol ester blocks UV-induced keratinocyte apoptosis (Haake and 
Polakowska, 1995). UV induction ofJunB, decease in c-Jun expression , 
and a rapid UV-induced increase in AP-1 immunoreactivity throughout 
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all epidennal cell layers , followed by an increase in the number of 
apoptotic keratinocytes , indicates a role of these proteins in UV­
induced apoptosis (Gillardon et aI, 1994). Loss of the apoptotic cellular 
defense against UV damage, by mutation in controlling genes, has 
deleterious effects. For example, the aberrations in regulation of 
apoptosis resulting from mutations in p53 partially accounts for the 
action ofUV radiation as a tumor promoter (see below) . 
The fact that apoptosis can be considered to be an adaptive response 
to stress in the epidermis suggests that apoptosis efficiency may impact 
on the organism's longevity. Indeed, the central role of stress adaptation 
in longevity has been brought to the forefront by studies of genes 
controlling aging in C. elegans. The nematode has been used widely 
in studies of genetic mechanisms regulating development and pro­
grammed cell death, and is becoming an increasingly important model 
for the study of aging (see Lithgow, this volume). Long-lived mutants 
with life expectancy extension from 40 to 100% have been isolated 
and partially characterized. Importantly, all mutants have exceptionally 
high resistance to environmental stresses such as high temperature, 
reactive oxygen species, and UV irradiation. Of these stressors UV is 
the most consistent predictor of life extension (Martin et aI, 1996). 
Resistance to stress-induced oxidative damage as a contributor to 
longevity is suggested by the fact that Age-1 mutants have enhanced 
expression of antioxidant enzymes superoxide dismutase (SOD) and 
catalase. Three other long-lived strains have mutations affecting the 
dauer fonnation pathway. Dauer is an altemative, stress-resistant devel­
opmental stage assumed in "hard times," again consistent with the idea 
that successful adaptation to stress leads to increased life-span. Recently 
both Age-1 and Daf-2 mutants have been identified as genetic 
components of the same signal transduction pathway linking control 
of the wonn's metabolism to longevity (Kimura et aI, 1997). This 
pathway also influences apoptosis in other systems (Kulik et aI, 1997). 
ROLE OF APOPTOSIS IN AGING: NON-SKIN SYSTEMS 
Is there any direct evidence that apoptosis plays a role in aging, in 
general? Two major features of human aging clearly have been linked 
to alterations in the incidence of cell death. These are immuno­
senescence and neurodegeneration. In each of these cases, it is not a 
simple task to separate intrinsic aging mechanisms from those that may 
result from specific pathologies, but it is still relevant to consider the 
role that apoptosis plays in generation of the disorders. 
As in the epidermis, programmed cell death is an important regulator 
of immune system homeostasis . Apoptosis plays a major role in T- and 
B-lymphocyte maturation and selection and excessive apoptosis is a 
characteristic of immunosenescence. It has been suggested that age­
associated immune dysfunction may correlate with defects (both 
increases and descreases) in apoptosis among different T cell subpopula­
tions (Nagel et aI, 1996; Warner et aI, 1997) . Studies show that there 
is an increase in memory T cells in aging humans . Memory T cells 
have an increased propensity to undergo apoptosis and their prevlance 
may thus partially explain the age-related decline of immune function 
(Nagel et aI, 1996). Another study showed that although there are no 
significant differences in apoptosis of the total CD3 + T cell population, 
older adults had increased apoptosis in the CD3+ CD45RO- T cell 
subpopulation , leading to a relative increase in CD45 RO+ T cells in 
aged individuals (Herndon et ai, 1997). This also may contribute to 
deficiencies in immune function because Ro + cells lead to clonal 
anergy (unresponsiveness) (Herndon et ai, 1997). Furthennore , there 
appears to be altered stress responses in old human lymphocytes 
Ourivich et ai, 1997). Lymphocytes from aged individuals are more 
sensitive to stress-induced but less sensitive to T cell receptor antibody­
induced apoptosis. Human lymphocytes exhibit an age-dependent loss 
in heat shock factor 1-DNA binding in vivo and in vitro. Uncoupling 
of heat shock uctor leading to apoptosis may account for premature 
apoptosis in aging lymphocytes Ourivich et aI, 1997). Defects in Fas! 
Fas ligand mediated apoptosis have been linked to the aging process. 
Mice bearing mutants in these proteins are short lived , but live longer 
under caloric restriction regimes (which presumably increase apoptosis) . 
Transgenic overexpression of fas results in maintenance of Fas-induced 
apoptosis and thymocyte counts (Zhou et a11995; reviewed in Warner 
et ai, 1997). 
JID SYMPOSIUM PROCEEDINGS 
Apoptosis plays a central role in age-related neurodegeneration. For 
example, the neurodegeneration of Alzheimer's disease has been shown 
to be associated with apoptosis and th e beta-amyloid protein induces 
apoptosis in vitro (Li et ai, 1996) and in transgenic mice (LaFerla et ai, 
1995). Oxidative damage and the resultant increases in apoptosis have 
also been suggested to be the underlying cellular mechanism of 
neurodegeneration in Parkinson's disease (Gonnan et aI, 1996) and 
Ataxia-telangiectasia. 
CHARACTERISTICS OF AGING SKIN: POTENTIAL ROLES 
OF APOPTOSIS 
Aging of the skin includes both intrinsic (chronologie) and extrinsic 
(photoaging) aging. Morphologic and biochemical parameters have 
been used to defme differences between intrinsically and photoaged 
skin (Ben-Sasson et aI, 1995; Yaar, 1996) by comparing sun-protected 
and sun-exposed skin from varied aged individuals. The major histologic 
features of sun-protected aged skin include flattening of the dennal­
epidennal junction, thinning of the dermis and subcutaneous adipose 
layer, and decreased numbers of keratinocytes, Langerhans cells, 
melanocytes, and mast cells. Photo damaged skin is characterized by an 
epidermis of varied thickness, and a further decrease in Langerhans 
cells but increased numbers of melanocytes. The most obvious UV­
induced changes are in the dermis with pronounced dermal elastosis 
and focal inflanunatory infiltrates. Although they are distinct, chrono­
logic aging and photoaging are interrelated in that intrinsic, age­
associated differences in gene expression and epigentic changes likely 
affect the old adult cell's response to extrinsic stress. 
What are the potential contributions of apoptosis to skin aging? One 
obvious feature of the intrinsically aged skin that may result from 
dysregulation of apoptosis is decreased or increased cellularity. Does 
increased apoptosis as aging progresses lead to loss of cells in the 
epidermis and dermis? Do regions of hyperplasia in sun-exposed 
epidermis result from an altered apoptotic program in response to 
stress? The second major issue that must be e=mined is epidermal 
neoplasia, a process that increases dramatically with aging. A wealth of 
evidence has led to a new theory of carcinogenesis . Once considered 
to be a disorder of proliferation, it is now widely accepted that an 
imbalance of the cell birth:cell death ratio determines abnormal 
growth associated with neoplasia . In order for a tumor to accomplish 
uncontrolled growth, it must escape the homeostatic protective response 
afforded by the apoptotic process. These topics are discussed in terms 
of their relevance to the aging process in human skin in the sections 
below with emphasis on the epidermal keratinocyte . 
GENES CONTROLLING EPIDERMAL APOPTOSIS ARE 
DYSREGULATED DURING SKIN AGING!SENESCENCE 
If there is a change in the level of apoptosis during the aging process 
then one would expect to find associated changes in the regulatory 
mechanism of apoptosis. There is a great deal of evidence showing 
that many of the genes exhibiting altered expression with aging! 
senescence also are important in the control of apoptosis . Cells, in 
general, lose their ability to maintain homeostasis as they age , whether 
in vivo or ill vitro. Changes in gene expression that have been 
documented include not only those genes involved in the response to 
growth factors and mitogens but also the response to environmental 
stress (discussed below). It is well established that senescent cells 
irreversibly arrest growth with a G1 DNA content and do not initiate 
DNA synthesis in response to mitogens (reviewed in Smith and Pereira­
Smith, 1996). The entire mitogen-response program is not lost, 
however, because some proto-oncogenes remain inducible. In general, 
most of the early response remains intact in the senescent cells from 
many different tissues. Senescent cells express a wide array of early 
response genes including c-myc, c-jun, and Ha-ras, but not c{os or the 
Id genes. Most profoundly, phosphorylation of retinoblastoma protein 
(Rb) and late G1 gene expression are repressed (reviewed in Campisi 
et ai, 1996; Smith and Pereira-Smith, 1996). 
Studies by Yaar and Gilchrest (reviewed in Yaar, 1996) have described 
many such changes in aging cells from the skin. By analysis of 
sun-protected skin (representing intrinsic aging) these investigators 
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discovered a significant chronologic age-associated decrease in cellular 
proliferative capacity for both keratinocytes and fibroblasts. Although 
the levels of many growth factors were found to be decreased in aging 
skin, old adult cells failed to respond even in the presence of adequate 
growth factors, suggesting a more downstream signal transduction 
defect. Consistently, many of the receptors were also downregulated, 
including epidermal growth factor receptor, androgen receptor, gluco­
corticoid receptor, and interleukin-II receptor. Even in the presence 
of adequate growth factors and functioning receptors, however, the 
induction of clos mRNA was blocked in aging fibroblasts, when 
stressed. Aging of skin cells therefore appears to be associated with a 
diminished capacity of the cell to upregulate important cell cycle 
regulatory genes, such as c1os, in response to various exogenous stimuli. 
Another major change is a decrease in the level ofRb phosphorylation 
in keratinocytes with increasing donor age, consistent with the lack of 
G 1 progression that is typical of senescent cells, in general. 
The above changes in gene expression of aging cells have been 
framed by investigators in the context of the effects on proliferative 
capacity, but we also may consider them in terms of their impact on 
regulation of apoptosis because many of the same genes regulate 
proliferation and apoptosis. How might dysregulation in growth factor 
signaling affect apoptosis? There is increasing evidence that survival of 
epidermal basal cells, as well as their continued proliferation, are 
promoted by autocrine and paracrine growth factors (reviewed in 
Polakowska and Haake, 1994; Haake and Polakowska, 1997), including 
epidermal growth factor, transforming growth factor-a, and dermally 
secreted keratinocyte growth factor. 
Another important apoptotic regulatory gene whose expression is 
changed with senescence is bcl-2. Consistent with it's role in suppression 
of apoptosis, bcl-2 is not suppressed by culture under adverse conditions 
in senescent cells that also are resistant to apoptosis (Wang, 1995) . 
Although bcl-2 overexpression increases resistance to apoptosis it is 
not sufficient to immortalize normal human keratinocytes (Nataraj 
et ai, 1994). 
There is overlap in other keratinocyte-expressed genes that regulate 
apoptosis and that are differentially expressed in senescent cells, although 
it is difficult to predict the outcome of their expression patterns because 
the relationships among cell cycle regulators are complex. For example, 
downregulation of cyclin A, an important regulator of cell cycle 
progression (Cortopassi and Clarke, 1996), is associated with both 
detachment-induced keratinocyte apoptosis and senescence of many 
cell types. Expression of Rb, p53, and p21Waf-1/cip, all inhi bitors of 
cell cycle progression, preceding onset of terminal differentiation! 
apoptosis in the epidermis, identifies them as candidate factors con­
tributing to committment of keratinocytes to apoptosis (reviewed in 
Cortopassi and Clarke, 1996). p21 also may act as a survival factor in 
the a bsence of p53 and is present in high levels in quiescent and 
senescent cells (Lui and Pelling, 1995). AP-1 transcription factor fumily 
genes, which are dysregulated during aging, also appear to be involved 
in terminal differentiation! apoptosis. c10s is downregulated in senescent 
cells whereas sustained expression of clos has been reported to precede 
cell death in the epidermis . Study of clos null mice, however, established 
that clos is not necessary for normal epidermal differentiation (Saez 
et ai, 1995) and blocking ofUV-induced clos expression by anti-sense 
oligonucleotides does not prevent UV-induced apoptosis, indicating 
that clos may not playa major role in the keratinocyte differentiation! 
apoptosis pathway (Gillardon et ai, 1994). 
INTRINSIC SKIN AGING: IS THERE EVIDENCE FOR 
CHANGES IN APOPTOSIS INCIDENCE? 
Apoptosis in vivo It might be predicted, considering the finding of 
age-related epidermal thinning and studies of neurodegeneration and 
irnmunosenescence, that apoptosis would be increased during skin 
aging and keratinocyte senescence i'1 vitro. No detailed studies are yet 
available that address this question. One approach to look for evidence 
of change in the overall incidence of apoptosis during chronologic or 
photo-aging is use of an in situ method known as TUNEL staining 
(Ben-Sasson et ai, 1995) to localize apoptotic cells in tissue sections. 
Comparisons of both the distributions and numbers of apoptotic 
c '. 
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Figure 1. TUNEL staining localizes apoptotic keratinocytes along the 
granuJar layer in the epidermis of human skin. (A) Neonatal foreskin 
epidermis; (B) adult sun-protected skin; (q ad�lt sun-exposed skin. (Modified 
from figure in Polakowska et aI, 1994.) 
keratinocytes in sun-protected skin from individuals of varied age 
(newborn, young, and old adult) would allow one to assess the overall 
levels of apoptosis during intrinsic aging . It is important to emphasize 
that the number of apoptotic cells visualized in a tissue at any point in 
time is only a "snapshot" of the process because apoptosis is a relatively 
short-lived, transient process. Nevertheless, our findings, to date, 
suggest that there may be a decreased rate of entry into the degradative 
phase of apoptosis!differentiation in the adult epidermis as compared 
with that of the newborn. TUNEL-staining studies of skin biopsies 
have shown that the numbers of apoptotic TUNEL + keratinocytes 
along the epidermal granular layer of new born skin are higher than in 
the granular layer of young or old adult epidermis (Fig 1). The rate 
of apoptotic-like DNA fragmentation , as part of terminal differentiation, 
may thus decrease in the epidermal keratinocytes with aging . These 
findings are consistent with other studies showing decreased epidermal 
cell turnover with aging, as determined by measurement of the 
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desquamation rate (Haratake et aI, 1997) . Premature apoptosis in the 
basal or spinous layer, associated with incomplete differentiation, would 
more likely contribute to a decrease in the overall numbers of epidermal 
keratinocytes with aging. Our limited studies, to date, show only 
occasional premature apoptotic cells but not an apparent increase with 
aging. Extensive sampling of sun-protected skin, however, representing 
the full range of the adult life-span, will be required to draw any fIrm 
conclusions regarding age-related changes in the rate of intrinsic 
apoptosis . This is an important area in need of further study. 
Apoptosis in vitro Available in vitro studies of epidermal keratinocytes 
have also £ailed to provide evidence, yet, of increased apoptosis with 
aging. In vitro replicative senescence has been used as a model of the 
intrinsic aging process to study spontaneous apoptosis in epidermal 
keratinocytes . Norsgaard et al (1996) studied cultured epidermal 
keratinocytes at increasing passage using morphologic parameters and 
assessed differentiation and apoptosis by expression of Types I and II 
transglutaminase, respectively. These investigators found that spon­
taneous apoptosis occurred at only low levels « 0 .1%) in culture and 
that the level did not change with increasing passage. Furthermore, 
differentiation did not occur spontaneously with in vitro aging. Senescent 
keratinocytes could be induced to differentiate but the process was 
slower than in replicatively competent cells. An important conclusion 
of these studies was that senescence of the epidermal keratinocyte is a 
distinct process and is not synonymous with either differentiation 
or apoptosis . 
EXTRINSIC SKIN AGING: EVIDENCE FOR ALTERED 
RESPONSE TO STRESS? 
Working models of the aging effects of the environment propose that 
age-related changes in basic processes affect the structure and function 
of proteins that regulate families of stress response genes. Moreover, 
these changes are accelerated when environmental insults are super­
imposed upon them. Papconstantinou (1994) contends that the major 
proteins affected are trans-acting factors including NF1(� , AP-1 ,  bZIP, 
or C/EBP family proteins, and heat shock factor. These are targeted 
by both biologic mediators and environmental stress factors via signal 
transduction pathways. For example, intrinsic factors, such as bypro ducts 
of oxidative metabolism that are continually being produced, activate 
Src kinases leading to AP-1 activation. One outcome is that aging cells 
may be under chronic stress (papaconstantinou, 1994) . These cells may 
then have altered response to additional stress that can potentially 
contribute to aging and disease. 
The role of apoptosis in this scenario has not yet been established 
but there is evidence that with intrinsic aging, there may be decreased 
efficiency of mechanisms that regulate apoptosis, and that this is 
accelerated by environmental insult. For example , there exists age­
related changes in DNA repair capacity (Moriwaki et ai, 1996), in the 
response to DNA damage mediated by p53 (Cortopassi et aI, 1996) 
and the growth-factor-deprived DNA damage inducible GADD genes 
(Yaar, 1996) . Age-related deficiencies in the antioxidant defense mech­
anism (Cortopassi and Clarke, 1996) with increasing chronologie age 
are thought to enhance photoaging as the skin is continually exposed 
to oxidative stress from its oxygen environment and from reactive 
oxygen species generated by UV irradiation. These stress conditions 
or stress related genes all are known to modulate apoptosis , thus 
identifying apoptosis as a key cellular mechanism that may be influenced 
by the effects of intrinsic and extrinsic aging. Based on fmdings of 
strong induction of GADD 153 in aged epidermal keratinocytes 
following growth factor withdrawal, upregulation in aged cells even 
after growth factor provision, and association of GADD gene activity 
with apoptosis induction in other systems, it has been suggested that 
aging is an apoptotic process aimed at eliminating dysfunctional cells 
(Yaar, 1996) . To the contrary, however, several studies have shown 
that senescent cells are resistant to apoptosis (Wang, 1995) . Our studies 
have shown that this may be true for the keratinocyte. Late passage 
keratinocytes, which exhibit a high proportion of cells with senescent 
morphology and which stain positively with senescence-associated �­
galactosidase (SA-�-gal; Dirnri et aI, 1995) , are more resistant to both 
UV-induced (Fig 2) and H20rinduced apoptosis. Decreased efficiency 
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A 
• 
B 
c 
Figure 2. TUNEL staining identifies apoptotic keratinocytes in cultures 
exposed to UVB (25 m] per cm2) and fixed 24 h post-irradiation. In 
first passage cultures (A), most keratinocytes are proliferative and are sensitive 
to induction of apoptosis, indicated by numerous cells with condensed nuclear 
morphology and positive TUNEL staining (arrowheads) . In both early and late 
passage (eighth; B) cultures, cells that are resistant to UV-induced apoptosis are 
those with large, flattened, irregular morphology typical of senescent 
keratinocytes (arrows) . (G) SA-�-gal staining of eighth passage keratinocytes 
demonstrates staining in numerous cells with characteristic senescent 
morphology. 
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Figure 3. Timeline of cancer development as modified from the 
discussion of Benson et al (1996) (see text). 
of apoptosis may be due to inability to cycle (Wang, 1995) or may be 
due to a state of chronic stress that leads to a failure in the normal 
resporue to additional stress (Papaconstantinou, 1 994) . To clarify these 
relatioruhips, it will be important to determine if aging, but not yet 
replicatively senescent, cells in the skin are more or less senstive to 
apoptosis and whether a state of chronic stress leads to increased or 
decreased apoptosis in these cells. In addition, comprehensive studies 
of apoptosis following UV irradiation of the skin of varied age 
individuals also are needed in order to assess the contribution of 
chronologie age-related skin changes to the apoptotic stress resporue 
in vivo. 
From a therapeutic point of view, regimens of caloric restriction 
(CR) that counter oxidative damage and extend life-span (Troyer and 
Fernandes, 1996) support a role of decreased apoptosis in the aging 
process. Rates of apoptosis are higher in animals maintained under 
CR than in animals fed ad libitum. It has been suggested that CR may 
work by decreasing the levels of oxidative stress in chronically stressed 
cells, with a resultant return to normal apoptotic homeostatic regulation 
(Troyer and Fernandes, 1996) . Other agents known to counter aging 
of the skin, such as vitamin A (retinoids), have antioxidative function 
and can reverse many age-related skin changes such as increases in 
collagenase production by fibroblasts, increases in pigmentation , and 
decreases in the thickness of the epidermis . The mechanisms of these 
retinoic acid-regulated changes are not fully understood but include 
direct and indirect regulation of gene expression, and control of 
keratinocyte proliferation . Apoptosis is known to be modulated by 
retinoids in other systems (Nagy et ai, 1995) and in the skin (Haake 
and Cooklis, 1 997), so that modulation of apoptosis by retinoids may 
signficantly contribute to their anti-aging effects. 
MUTATIONS IN GENES CONTROLLING THE 
PROTECTIVE APOPTOTIC RESPONSE TO STRESS/ 
DAMAGE CONTRIBUTE TO THE DEVELOPMENT OF 
NEOPLASIA 
According to the multistage carcinogenesis model, cells must acquire 
mutations in several genes for malignant transformation. The discovery 
that many oncogenes and anti-oncogenes belong to the apoptotic 
pathway identified cell death as an important factor in development 
of neoplasia. Normal tissue homeostasis is achieved by a balance in cell 
birth:cell death. Tipping the scales in favor of either proliferation or 
cell death can disrupt homeostasis. This may help to explain the well­
known timeline of cancer onset as discussed by Benson et al (1996; 
see Fig 3) . Up to approximately age 30 there is a period of relative 
homeostasis where cell proliferation and cell death rates are balanced. 
Accumulation of DNA damage with aging, however, may lead to 
mutations in genes controlling proliferation and apoptosis . Damaged. 
normally quiescent cells may re-enter the cell cycle and may also be 
defective in apoptosis . Increase in cell proliferation and! or a decrease 
in the rate of apoptosis would result in irnbIance of the cell birth:cell 
death ratio and accumulation of cells harboring mutations. Increase in 
cell division alone apparently is not sufficient for continuous tumor 
development. To achieve net growth. it appears that tumors may 
require changes that suppress apoptosis because increased apoptosis is 
a homeostatic response to increased proliferation. Benson (1 996) argues 
that there is a diminished rate of increase in cancer in the elderly due 
to an increase in senescent cells that have decreased efficiency of 
apoptosis but that are also unable to divide. This hypothesis fails to 
take into account possible deleterious effects of altered differentiation 
in senescent cells (see Campisi et al. this volume) . It is clear, however, 
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that dysregulation of apoptosis through intrinsic aging processes or 
through random mutation hence has the potential to strongly infiuence 
the onset of cancer. 
Study of the skin has provided much evidence that mutation in 
genes controlling apoptosis contributes to neoplastic progression (for 
review see Haake and Polakowska, 1 997 ; references therein) . Escape 
from apoptosis functions primarily at the level of tumor promotion, 
allowing initiated cells to clonally expand . Evidence that this occurs 
in viv o comes from fmdings of frequent clonal populatioru of keratino­
cytes bearing p53 mutations in otherwise healthy adult epidermis 
aonason et ai, 1 996) . Survival of the initiated cell through loss of the 
ability to undergo apoptosis gives the mutant cell a selective advantage 
under stressful conditions and contributes to further clonal expansion. 
Moreover, survival-mediated clonal expansion leads to neoplasia by 
allowing the initiated cell to acquire additional mutations. In support 
of this model, there is high incidence of UV-induced loss-of-function 
mutations in p53 in squamous cell carcinoma and a high correlation 
between Bcl-2 expression and c-myc expression in basal cell carcinoma, 
squamous cell carcinoma, and cutaneous lymphomas, indicating that 
c-myc may be a "second-hit. "  Age-related changes in a cell's response 
to oxidant stress could affect the onset of neoplasia. For example, 
keratinocytes of a transformed cell line that is sensitive to tumor 
promotion by oxidants expand clonally because they have a superior 
antioxidant defense (or improved calcium buffering) ,  whereas resistant 
cells undergo oxidant-induced apoptosis accompanied by a sharp rise 
in intracellular calcium. 
Imrnunosenescence resulting from increased thymocyte apoptosis 
may also impact on the development of neoplasia because survival of 
the traruformed cell in the heterogeneous multicellular milieu of the 
skin is another factor crucial to tumor progression. Anti-tumor activity 
is conferred by epidermal dendritic cells and infiltrating lymphocytes 
against highly immunogenic skin tumors , such as squamous cell 
carcinoma and cutaneous lymphoma, by a Fas-dependent pathway, or 
via the perforin and granzyme FAS-independent pathways . Apoptotic 
deletion of these cells could lead to a failure of imrnunosurveillance 
and an escape mechanism for the transformed cell. 
AGE-RELATED CHANGES IN MELANOCYTE NEVI: 
ROLE OF APOPTOSIS 
Melanocytic nevi in the skin exhibit a characteristic "lifecycle," 
increasing in number in childhood and early adult life and involuting 
after approximately age 40 (Morales-Ducret et ai, 1995) . There is 
some evidence that apoptosis contributes to decreasing numbers of 
melanocytes with aging. Bcl-2 expression, normally high in melanocytes 
and nevi, is decreased in neurotized areas of benign nevi, leading the 
authors to suggest that the disappearance of melanocytic nevi with 
increasing age could be attributable to Bcl-2 loss. Progression of 
melanoma also involves apoptotic dysregulation. Loss of c-kit, the stem 
cell factor receptor, apparendy leads to resistance of the melanoma cell 
to apoptosis, and survival in the stem cell factor-rich milieu of the 
epidermis (Huang et ai, 1 996) . 
ELONGATION FACTOR (EF)-1a.: POSSmLE ROLES IN SKIN 
AGING. IMMORTALIZATION, AND NEOPLASIA? 
Our laboratory is now focusing on the possible role of EF-1a. in 
human skin aging and carcinogenesis. EF-1a. mRNA is upregulated 
in epidermal keratinocytes by two important modulators of skin aging. 
UV (Rosen et al. 1995) and retinoic acid (Fig 4) . 1  Both EF- 1 a.  
mRNA (Fig S)  and protein levels decline with progressive passage of 
keratinocytes in culture. Age-related changes in expression of EF-1a. 
have also been shown in nonskin systems (Cavallius e t  ai, 1 986; 
Giordano et al. 1989). 
Although EF-1 a. is ubiquitously expressed and abundant. tight 
regulation of EF-1 a.  expression appears to be important for normal 
cell function. Elevated levels of EF-1 a.  are associated with increased 
1 Alexander CA, Haake AR: Induction of elongation factor-l alpha by 
retinoic acid in fetal keratinocytes. ] Invest Dermatol l04:674 (abstr.) 
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Figure 4. Stage-specific up regulation of the 1.6 kb EF-la mRNA by 
retinoic acid in human keratinocytes. Northern blot of EF-la transcripts 
present in cultured neonatal and fetal keratinocytes treated with all-trans retinoic 
acid (10--{' M) or vehicle H under low-calcium conditions. The major 1 .6  kb 
EF-la transcript is upregulated in fetal keratinocytes following 6 h exposure 
to retinoic acid. A 2.2 kb EF-la. transcript is present in neonatal keratinocytes. 
Transcripts were quantitated and normalized against rRNA probe PHE7 (arrow) 
following longer fihn exposure of the same blot. 
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Figure 5. EF-la mRNA levels decline as keratinocytes approach 
senescence. Quantitation of the 1 .6 kb EF-1a transcript present in serially 
passaged (passage 2-12) neonatal keratinocytes following northern blot analysis 
shows a decline in the steady-state levels of EF-la mRNA as cells approach 
the end of their replicative life-span (P 1 2) .  Levels of EF-la transcript are 
expressed relative to two different internal controls, GAPDH and �-actin. 
proliferation, transfonnation, metastasis, and delayed senescence 
(Cavallius et ai, 1986; Giordano and Foster, 1989; Tatsuka et ai, 1992; 
Edmonds et ai, 1996; Sun et ai, 1997) . Total cellular protein levels of 
EF-1a are higher than other translation factors, and higher than are 
required to catalyze protein elongation, suggesting that EF-1a has 
other functions (Condeelis, 1995) . In fact, although best known for its 
role as the rate-limiting factor in the elongation phase of protein 
translation, EF-1a is a multifunctional protein. Other functions include 
severing of microtubules, actin binding and bundling (Condeelis, 1995; 
Saez et ai, 1 995; Murray et ai, 1996) ,  and participation in signal 
transduction (Yang et ai, 1 993; Yanigahara et ai, 1997) . 
How might decreases in EF-1a with skin aging affect keratinocyte 
homeostasis? We have approached this question experimentally using 
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a sense/anti-sense eDNA overexpression strategy. Our data show 
that anti-sense overexpression in HaCaT keratinocytes alters the 
organization of the actin cytoskeleton and causes a delay in both 
epidennal growth factor-induced keratinocyte proliferation and UV­
induced apoptosis . In contrast, sense overexpression accelerates both 
epidennal growth factor-induced proliferation and UV-induced 
apoptosis (Roublevskaia and Haake, in preparation) .2 Based on these 
findings we speculate that age-related changes in EF-1a protein levels 
or distribution in keratinocytes may contribute to aging processes 
through EF-l a modulation of the cytoskeleton. The actin cytoskeleton 
is known to profoundly affect the ability of cells to respond to growth 
factor stimulation, cell motility, and migration, and the sensitivity to 
apoptosis induction. Interestingly, senescent cells have a rigid actin 
cytoskeleton , and exhibit deficiencies in the normal dynamics of 
cytoskeletal polymerization/depolymerization in response to environ­
mental influences (Molitoris, 1 997) . Significant decreases in the abund­
ance or function of EF-la, as cells approach replicative senescence, 
may alter the cell's ability to respond to stress and growth factor 
activated signal transduction pathways, which involve cytoskeletal 
reorganization and which lead to cell proliferation or apoptosis. 
FOCUS FOR FUTURE STUDffiS 
The role of apoptosis in aging of the skin and other systems is just 
beginning to be addressed. It will be important to carefully document 
the incidence of apoptosis in sun-protected as well as sun-damaged 
skin. Along with the other skin disorders in which apoptosis plays a 
role, the aging field is a potential fruitful area of phannaceutical 
development. To potentiate effectiveness of a variety of agents, identi­
fication of the controllable points of apoptosis and development of 
specific activators and inhibitors of these pathways are expected to be 
maj or advances . 
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